BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24808540)

  • 1. Role of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the renal 2',3'-cAMP-adenosine pathway.
    Jackson EK; Gillespie DG; Mi Z; Cheng D; Bansal R; Janesko-Feldman K; Kochanek PM
    Am J Physiol Renal Physiol; 2014 Jul; 307(1):F14-24. PubMed ID: 24808540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.
    Verrier JD; Jackson TC; Gillespie DG; Janesko-Feldman K; Bansal R; Goebbels S; Nave KA; Kochanek PM; Jackson EK
    Glia; 2013 Oct; 61(10):1595-606. PubMed ID: 23922219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Is an Important Determinant of AKI Severity after Ischemia-Reperfusion.
    Jackson EK; Menshikova EV; Mi Z; Verrier JD; Bansal R; Janesko-Feldman K; Jackson TC; Kochanek PM
    J Am Soc Nephrol; 2016 Jul; 27(7):2069-81. PubMed ID: 26574047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.
    Verrier JD; Jackson TC; Bansal R; Kochanek PM; Puccio AM; Okonkwo DO; Jackson EK
    J Neurochem; 2012 Jul; 122(1):115-25. PubMed ID: 22360621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular 2,3-cyclic adenosine monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth [corrected].
    Jackson EK; Ren J; Gillespie DG; Dubey RK
    Hypertension; 2010 Jul; 56(1):151-8. PubMed ID: 20516392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular cAMP-adenosine pathways in the mouse kidney.
    Jackson EK; Ren J; Cheng D; Mi Z
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F565-73. PubMed ID: 21653635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of cAMP to adenosine in the renal vasculature.
    Jackson EK; Mi Z; Gillespie DG; Dubey RK
    J Pharmacol Exp Ther; 1997 Oct; 283(1):177-82. PubMed ID: 9336322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular 2',3'-cAMP and 3',5'-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cells.
    Jackson EK; Gillespie DG
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F954-62. PubMed ID: 22791337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-adenosine pathway in the proximal tubule.
    Jackson EK; Zacharia LC; Zhang M; Gillespie DG; Zhu C; Dubey RK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1219-29. PubMed ID: 16527902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Roles of 2',3'-cAMP in Biological Systems.
    Jackson EK
    Handb Exp Pharmacol; 2017; 238():229-252. PubMed ID: 26721674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth.
    Dubey RK; Mi Z; Gillespie DG; Jackson EK
    Hypertension; 1996 Nov; 28(5):765-71. PubMed ID: 8901821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular 2',3'-cAMP is a source of adenosine.
    Jackson EK; Ren J; Mi Z
    J Biol Chem; 2009 Nov; 284(48):33097-106. PubMed ID: 19801686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
    Jackson EK; Gillespie DG
    Am J Physiol Renal Physiol; 2013 Jan; 304(1):F49-55. PubMed ID: 23077101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.
    Jackson EK; Mi Z; Janesko-Feldman K; Jackson TC; Kochanek PM
    Am J Physiol Regul Integr Comp Physiol; 2019 Jun; 316(6):R783-R790. PubMed ID: 30789788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an endogenous cAMP-adenosine pathway in the rat kidney.
    Mi Z; Jackson EK
    J Pharmacol Exp Ther; 1998 Dec; 287(3):926-30. PubMed ID: 9864274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP.
    Verrier JD; Kochanek PM; Jackson EK
    J Pharmacol Exp Ther; 2015 Aug; 354(2):175-83. PubMed ID: 25998049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.
    Jackson EK; Ren J; Gillespie DG
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H391-401. PubMed ID: 21622827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Involvement of 2',3'-Cyclic Nucleotide-3'-Phosphodiesterase in the Protein Phosphorylation-Mediated Regulation of the Permeability Transition Pore.
    Baburina Y; Odinokova I; Azarashvili T; Akatov V; Sotnikova L; Krestinina O
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30405014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.
    Jackson EK; Gillespie DG; Dubey RK
    J Pharmacol Exp Ther; 2011 May; 337(2):444-50. PubMed ID: 21270135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2',3'-cAMP-adenosine pathway.
    Jackson EK
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1160-7. PubMed ID: 21937608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.